1308eP Efficacy of isatuximab plus dexamethasone versus non isatuximab-based treatments in refractory multiple myeloma: A systematic review and meta-analysis

Víctor CastilloLuis E. Cueva-CañolaAlex TorresA. PérezAlejandro Campos-MuñozAbraham Zenteno-AguilarKaroly Pamela Zuñiga MontañoSergio Morales AcostaWagner Rios-GarcíaCarlos Eduardo Espinosa Temaxte2026-03-222026-03-22202510.1016/j.annonc.2025.08.1942https://doi.org/10.1016/j.annonc.2025.08.1942https://andeanlibrary.org/handle/123456789/85974enMedicineRefractory (planetary science)DexamethasoneInternal medicineOncologyPharmacologyClinical trial1308eP Efficacy of isatuximab plus dexamethasone versus non isatuximab-based treatments in refractory multiple myeloma: A systematic review and meta-analysisreview